Article - 
Limited access to UNIGEOther version: http://onlinelibrary.wiley.com/store/10.1111/j.1538-7836.2008.03241.x/asset/j.1538-7836.2008.03241.x.pdf?v=1&t=gzs402...
Highlights
Scientific Article - Comment
unige:19813 
 |
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? |
|
| Authors | ||
| Published in | Journal of thrombosis and haemostasis. 2009, vol. 7, no. 2, p. 363-364 | |
| Keywords | Bias (Epidemiology) — Biomedical Research/standards — Cardiovascular Diseases/drug therapy — Humans — Platelet Aggregation Inhibitors/*therapeutic use — Ticlopidine/analogs & derivatives/therapeutic use | |
| Identifiers | PMID: 19036060 | |
| Full text |
Article - Limited access to UNIGE Other version: http://onlinelibrary.wiley.com/store/10.1111/j.1538-7836.2008.03241.x/asset/j.1538-7836.2008.03241.x.pdf?v=1&t=gzs402... |
|
| Structures | ||
| Research groups | Anticorps antiphospholipides (12) Geneva Platelet Group (13) | |
| Citation (ISO format) | FONTANA, Pierre, DE MOERLOOSE, Philippe, RENY, Jean-Luc. Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?. In: Journal of thrombosis and haemostasis, 2009, vol. 7, n° 2, p. 363-364. doi: 10.1111/j.1538-7836.2008.03241.x https://archive-ouverte.unige.ch/unige:19813 |
412 hits 
0 download 
Contact an author
Update